Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.1 (
aspartate aminotransferase
)
21,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum
guanase
,
aspartate aminotransferase
, alanine aminotransferase, creatine phosphokinase and hydroxybutyrate dehydrogenase activities were measured in 290 blood samples from 96 consecutive patients admitted to a Coronary Care Unit. Elevated serum
guanase
activities (greater than 2 U/l) were found in 19 patients (20%). The magnitude and frequency of these elevations did not negate the value of
guanase
as a "liver function test", since all cases with raised
guanase
also had abnormal serum alanine aminotransferase activities. This fact, together with other information in the literature, indicated that elevated serum
guanase
activity following myocardial infarction was consequent upon some degree of sub-clinical hepatic necrosis. Caution must be exercised when serum asparate aminotransferase is used as an index of heart muscle necrosis unless
guanase
or some other "liver specific" enzyme is known to be normal, or unless creatine phosphokinase or hydroxybutyrate dehydrogenase activities are elevated.
...
PMID:Serum guanase activities after myocardial infarction. 117 93
1. The effect of demographic variables such as age, sex, body weight, social class and blood pressure upon the activity of serum enzymes in healthy humans is reviewed. A system developed by the author and his colleagues, which automatically adjusts the results of enzyme activity measurements to allow for demographic influences, is described. This allows derivation of a "demographically corrected" normal range; for most enzymes this range is much narrower than that provided by the conventional mean +/- 2 SD approach. 2. The influence of precision and analytical factors upon the normal range for serum enzymes is discussed. Data from a British national quality-control survey reveal a depressing picture of interlaboratory precision for commonly determined enzyme estimations. Examples are given (serum
aspartate aminotransferase
and
guanase
) which illustrate the influence that precision of a method may have on the normal range for that enzyme.
...
PMID:Demographic and analytic factors affecting the normal range of serum enzyme activities. 127 52
We have developed a sensitive method for the measurement of rhodanese activity in human serum which is based on the colorimetric method for the determination of thiocyanate produced from methanethiosulfonate and cyanide as substrates. Thiocyanate gives a red complex with ferric ion in an acidic condition. The present method is about 70-fold more sensitive than the conventional method using cyanide and thiosulfate as substrates and correlates well (r = 0.997) with the conventional method in bovine liver rhodanese. Within-run precision of the method is 0.91% for 420 units/l serum and the calibration curve is linear up to 1850 units/l. The normal value for human serum, determined by the present method on 31 healthy persons, was 20.9 +/- 20.0 units/l (mean +/- 2S.D.). Rhodanese activity was clearly elevated in some serum samples which were observed at abnormal values in some biochemical diagnostic tests and showed significant positive correlations with
guanase
activity (r = 0.728, p less than 0.01) and
glutamic-oxalacetic transaminase
activity (r = 0.625, p less than 0.01).
...
PMID:Improved method for measurement of rhodanese activity using methanethiosulfonate as sulfur donor substrate and its application to human serum. 166 23
Elevated levels of serum enzymes are frequently associated not only with alcohol-related organ damage but also with excessive alcohol consumption and alcoholism without significant tissue injury. However, both in the early detection of alcoholism as well as also in the diagnosis of alcohol-related diseases the sensitivities and specificities of these enzyme markers vary considerably. They may be influenced by nonalcohol-related diseases, enzyme-inducing drugs, nutritional factors, metabolic disorders, age, smoking, etc. Consequently, we have neither a single laboratory test--enzyme marker--nor a test combination that is reliable enough for the exact diagnosis between alcohol- and nonalcohol-related organ damage. In most cases it is possible to determine the tissue from which the elevated enzyme is derived, but only occasionally enzyme changes reflect the quantity of the tissue injury. Gamma-glutamyltransferase (GGT) is the most widely used laboratory marker of alcoholism and heavy drinking, detecting 34-85% of problem drinkers and alcoholics. However, the unspecificity of increased serum GGT limits its use for general screening purposes. Its value in the follow-up of various treatment programs, however, is well established. An elevated level of serum
aspartate aminotransferase
(
ASAT
) and alanine aminotransferase (ALAT) in an alcoholic or a heavy consumer indicates alcohol-induced organ damage. The use of test combinations significantly improves the information received with single serum enzyme determinations. An
ASAT
/ALAT ratio greater than 1.5 can be considered as highly suggestive for the alcoholic etiology of the liver injury. Still better discrimination between alcoholic and nonalcoholic origin of the liver disease may be achieved by the determination of the ratio of GGT to alkaline phosphatase. If this ratio exceeds 1.4 the specificity of the finding in favor for alcoholic liver injury is 78%. The determination of the mitochondrial isoenzyme of
ASAT
also improves the diagnostic value of
ASAT
determination. The ratio of mitochondrial isoenzyme to total over 4 is highly suggestive for alcohol-related liver injury. In general, however, the determination of serum activities of other enzymes such as ornithine carbamyl transferase, lactate dehydrogenase, isocitrate dehydrogenase, sorbitol dehydrogenase, alcohol dehydrogenase,
guanase
, aldolase, alkaline phosphatase or glutathione S-transferase do not significantly improve the diagnostic information obtained with more conventional laboratory markers of liver injury.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Use of enzymes for the diagnosis of alcohol-related organ damage. 243 6
Forty-one patients with chronic hepatitis were divided into an HBe antigen-positive group (n = 13) and an HBe antigen-negative group (n = 28) to clarify the relationship between the presence of HBe antigen and liver function. In the HBe antigen-positive group, the activities of serum alanine aminotransferase (p less than 0.01),
aspartate aminotransferase
(p less than 0.05) and
guanase
(p less than 0.01) were significantly higher than those in the HBe antigen-negative group. The correlation coefficient between the HBe antigen titer and
guanase
activity was 0.528, which was higher than the corresponding values for alanine aminotransferase and
aspartate aminotransferase
. The determination of
guanase
activity in serum may be useful for evaluating the clinical severity of HBe antigen-positive chronic hepatitis.
...
PMID:[Activity of guanase in serum and liver function tests in HBe antigen-positive chronic hepatitis]. 261 68
A total of 1020 hospital employees were divided into an exposure group (n = 725) and a non-exposure group (n = 295), based on whether they had been exposed to blood from patients. The HBsAg-positive rates for the exposure and the non-exposure groups were 2.48% and 1.02%, respectively. In the exposure group, the minimal exposure rate increased with age from the twenties. The odds ratios were 7.39 in the technicians, 4.38 in physicians and 1.32 in nurses. Using age-sex matched pairs from the exposure and non-exposure groups, comparison of
aspartate aminotransferase
, alanine amino-transferase and
guanase
activities showed that there were significantly higher values in HBsAg-positive subjects (n = 18) from the exposure group than in HBsAg- and HBsAb-negative subjects from the non-exposure group (p less than 0.05-0.01). However, no significant differences were found in the enzyme activities in the matched pairs (n = 89) of HBsAb-positive subjects from the exposure and non-exposure groups.
...
PMID:Epidemiological study of occupational exposure to hepatitis B virus and liver function tests. 278 11
We measured serum
guanase
(
EC 3.5.4.3
) activity in patients with various diseases and in healthy controls, and evaluated the clinical usefulness of this enzyme in liver diseases. The reference range, which showed no significant difference between sexes and ages over the range studied, was 0 to 1.8 U/L. The mean
guanase
activities for patients with various liver diseases, including acute hepatitis, chronic hepatitis, liver cirrhosis, hepatoma and metastatic carcinoma, were above the upper limit of the reference range. In acute hepatitis and metastatic carcinoma of the liver, the activities were especially high. Validity (sensitivity + specificity) of
guanase
, which in all tests was above 1.66, was compared to that of
AST
and ALT in liver diseases. With
guanase
, the highest validity (1.98) was found in acute hepatitis and metastatic carcinoma. Specificity of
guanase
was 0.98, whereas sensitivity of
AST
was 1.00 in all diseases. Sensitivity and specificity of ALT were 0.85 to 0.97 in all diseases. As
guanase
was specific, including this enzyme with other liver function tests, such as
AST
and ALT, may decrease false-positive results and may be effective for prediction of liver disease.
...
PMID:Clinical evaluation of serum guanase activity in liver diseases. 649 63
To find ways of predicting survival or death in cases of severe shock, arterial blood pH and gases, vital signs, and the half-life of activity in the enzymes
guanine deaminase
,
aspartate aminotransferase
(
AST
) and alanine aminotransferase (ALT), were studied in 24 patients. The mean arterial blood pH (+/- SD) in survivors was 7.325 +/- 0.092 while that in non-survivors was 7.108 +/- 0.251 (p less than 0.05). The mean half-life of
guanine deaminase
in survivors was 19.8 +/- 3.3 hours, while that in non-survivors was 58.6 +/- 11.8 hours (p less than 0.001). When the screening values were set at 7.190 for the arterial blood pH and 36 hours for the half-life of
guanine deaminase
activity, the 'validity' (sensitivity plus specificity) for the combination of the two tests was 1.88. The values may be useful for the prognosis of survival in severe shock patients.
...
PMID:Guanine deaminase in serum as an indicator of survival probability in severe shock patients. 688 11
Of 150 patients undergoing regular hemodialysis (HD), 14 (9.3%) and 12 (8.0%), respectively, showed low serum activity of
aspartate aminotransferase
(
AST
) and alanine aminotransferase (ALT). An investigation was conducted to elucidate the underlying mechanisms in 20 patients with low serum
AST
and/or ALT activity. Fifty-five percent of the patients with low aminotransferase activity manifested serum levels of pyridoxal phosphate (PLP) that were lower than normal. Serum PLP levels correlated neither with
AST
nor with ALT activity. Oral administration of vitamin B6 to the cases with low aminotransferase activity resulted in an increase in pre-hemodialysis aminotransferase activity. Addition of vitamin B6 in vitro to the sera from the patients with low aminotransferase activity did not increase the values when the added vitamin B6 was within the physiological range, but did increase when added in larger (pharmacological) amounts. However, aminotransferase activity increased, but PLP levels remained unchanged when these values were compared before and after HD. On the other hand,
guanase
being within the normal range in all cases studied, did not change after HD. Although our study does not correlate with vitamin B6 deficiency, but rather with some uremic substance(s) which interfere(s) with the enzyme reaction as a cause of low aminotransferase activity, the fact that less than 10% of our patients showed low
AST
and/or ALT points to the latter possibility, suggesting the need of further study.
...
PMID:Low serum aminotransferase activity in patients undergoing regular hemodialysis. 802 12
A simple high-performance liquid chromatography (HPLC) assay for the simultaneous determination of
guanase
and
aspartate aminotransferase
(
AST
) activities in a single serum sample is described. The method is based on direct detection of enzymatically formed products xanthine and glutamate, respectively. The procedure is sensitive, precise (C.V. below 2% for
guanase
and 3% for
AST
), suitable for routine purposes and requires only 100 microliters of sample. Kinetic measurements have shown the
guanase
activity to have an apparent Michaelis constant of 24.5 microM and the
AST
activity of 11.1 and 0.18 mM for aspartate and oxoglutarate, respectively, at 37 degrees C in Tris-HCl buffer (pH 7.5).
...
PMID:Simultaneous assay for aspartate aminotransferase and guanase in human serum by high-performance liquid chromatography. 908 Mar 15
1
2
Next >>